思派健康科技有限公司（00314）于2026年2月3日发布翌日披露报表，公告该公司在香港联交所回购股份。根据公告，公司于2026年2月3日按每股2.63港元至2.76港元的价格区间，回购合计1,656,000股普通股，涉资约4,529,460港元。本次回购股份占回购前公司已发行股本（不包括库藏股）约0.223%。
回购完成后，公司已发行股本（不包括库藏股）变动至742,055,514股，库藏股数量增至23,522,600股，已发行股份总数保持765,578,114股。公告显示，股东大会已于2025年6月20日通过购回授权，授权总数为75,022,471股；截至目前，公司已根据授权回购9,342,800股，占授权总量的1.245%。
公告确认，本次回购行为已遵循上市规则和相关法律程序，并由公司秘书任娜签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.